Studying drug excretion into exhaled breath aerosol – A workflow based on an impaction sampling device and LC-HRMS/MS analysis
Analytica Chimica Acta · 2024
DOI: 10.1016/j.aca.2024.342991 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2024. Verfasst von Juel Maalouli Schaar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signalin…. Hauptthemen laut MEDLINE: Aerosols, Tandem Mass Spectrometry, Breath Tests. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung., Deutsche Herzstiftung.
Abstract (Originalsprache)
BACKGROUND: Exhaled breath (EB) aerosol was in principle shown to be a suitable matrix for bioanalysis of volatile but also non-volatile compounds. This attracted particular interest in the field of drug analysis. However, a big gap still exists in the understanding how and which drugs and/or their metabolites are excreted into exhaled breath and could thus actually be detected. The current study aimed to develop an analytical workflow for the qualitative detection of non-volatile drugs in EB aerosol microparticles. RESULTS: The analyte selection covered different drug classes such as antihypertensives, anticonvulsants or opioid analgesics to investigate and understand the excretion of drugs and their metabolites into EB aerosol. A device for collecting aerosol particles from the lung through impaction was used for the non-invasive sampling procedure. Three expiration cycles per participant and device were collected. The sample preparation consisted of a collector extraction with methanol. Qualitative method development and validation were performed using reversed-phase liquid chromatography (LC) coupled to orbitrap-based high-resolution mass spectrometry (HRMS). Qualitative method validation was done according to published recommendations and international guidelines. Parameters such as selectivity, carry-over, limits of detection and identification, recovery, matrix effects, and long-term stability were evaluated. The limits of detection ranged from 100 pg/collector to 10,000 pg/collector. The procedure was finally used to analyze a total of 31 patient EB samples and demonstrated that e.g., tilidine and its metabolite nortilidine as well as tramadol and its active metabolite O-desmethyltramadol can be detected in EB aerosol. SIGNIFICANCE AND NOVELTY: The work shows a comprehensive workflow for elucidating drug excretion into exhaled breath aerosol. This bioanalytical strategy and the corresponding novel data from this study are the foundation for further method development and to better understand, which drugs and their metabolites can be addressed by exhaled breath aerosol bioanalysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.
- Department of Internal Medicine III, Cardiology, Angiology and Intensive Care Medicine, University Hospital Saarland, Saarland University, Homburg, Germany; Department of Cardiology, Heart Center at University Hospital…
- Karolinska Institute, Clinical Neuroscience, Stockholm, Sweden.
- Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany. Electronic address: m…
Förderung
- Deutsche Forschungsgemeinschaft
- Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.
- Deutsche Herzstiftung
- Deutschen Gesellschaft für Klinische Neurophysiologie und Funktionelle Bildgebung
Zitieren
APA
Maalouli Schaar, J., Kunz, M., Wagmann, L., Beck, O., Mahfoud, F., & Meyer, M. R. (2024). Studying drug excretion into exhaled breath aerosol – A workflow based on an impaction sampling device and LC-HRMS/MS analysis. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2024.342991
Vancouver
Maalouli Schaar J, Kunz M, Wagmann L, Beck O, Mahfoud F, Meyer MR. Studying drug excretion into exhaled breath aerosol – A workflow based on an impaction sampling device and LC-HRMS/MS analysis. Analytica Chimica Acta. 2024. doi:10.1016/j.aca.2024.342991
BibTeX
@article{MaalouliSchaar2024,
author = {Maalouli Schaar, Juel and Kunz, Michael and Wagmann, Lea and Beck, Olof and Mahfoud, Felix and Meyer, Markus R},
title = {Studying drug excretion into exhaled breath aerosol – A workflow based on an impaction sampling device and LC-HRMS/MS analysis},
journal = {Analytica Chimica Acta},
year = {2024},
doi = {10.1016/j.aca.2024.342991}
}
EUVIMED